Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III data presented on fexuprazan in patients with erosive esophagitis

May 13, 2020

ALS-8112, a parent nucleoside of lumicitabine, inhibits Nipah virus in vitro

May 13, 2020

AQX-435 shows promising activity in models of B-cell malignancies

May 13, 2020

Decreased SLC39A1 expression is associated with poor prognosis in HCC

May 13, 2020

GALNT14 GG genotype as prognostic biomarker in PDA

May 13, 2020

Tukysa approved in Switzerland for metastatic HER2-positive breast cancer

May 13, 2020

Sorrento Therapeutics and Mount Sinai partner on antibody cocktail for COVID-19

May 13, 2020

Integrated herpesvirus 6 is pre-eclampsia risk factor

May 13, 2020

Genfit reports phase III interim data on elafibranor in NASH

May 12, 2020

Phase III study of Sarclisa in relapsed multiple myeloma meets primary endpoint

May 12, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...